Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables
Open Access
- 1 August 1998
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 102 (3) , 729-739
- https://doi.org/10.1046/j.1365-2141.1998.00818.x
Abstract
We determined the proportion of survival variability explained by the usual prognostic factors in childhood acute lymphoblastic leukaemia (ALL) during a prognostic study of 1552 patients enrolled in three consecutive Fralle group protocols (Fralle 83, Fralle 87 and Fralle 89). The event‐free survival rates at 5 years were 54.8% (SD 1.9), 43.1% (SD 2.7) and 55.6% (SD 2.2), respectively. In the univariate analysis the following variables were predictive of poor outcome: male gender, elevated leucocytosis (> 50 × 109/l), circulating blastosis, haemoglobin >12 g/dl, platelet count 400 U/l. Among the cytogenetic features, hyperdiploidy had a protective effect, whereas hypodiploidy, translocation and other structural abnormalities had a negative influence, particularly in cases of t(9;22) or t(4;11). Multivariate analysis summarized the prognostic information in terms of four variables: age, gender, leucocytosis and cytogenetic features. Missing data had little influence on the results. However, despite their significance in the multivariate analysis, these four variables each had very low predictive power (1.1% for gender, 2.0% for age, 3.5% for leucocytosis, and 1.6% for cytogenetic features). Thus, the most significant prognostic factors in childhood ALL each explain no more than 4% of the variability in prognosis. This may explain the disappointing practical value of these factors and underlines the need for prognostic tools in childhood ALL.Keywords
This publication has 51 references indexed in Scilit:
- Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12 000 randomised childrenThe Lancet, 1996
- Clinical relevance of in vitro drug resistance testing in childhood acute lymphoblastic leukemia: The state of the artMedical and Pediatric Oncology, 1994
- Cytomorphology of childhood lymphoblastic leukaemia: a prospective study of 2000 patientsBritish Journal of Haematology, 1992
- Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (Report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood)British Journal of Haematology, 1991
- Clinical Importance of Myeloid-Antigen Expression in Acute Lymphoblastic Leukemia of ChildhoodNew England Journal of Medicine, 1991
- A note on a general definition of the coefficient of determinationBiometrika, 1991
- Infant acute lymphoblastic leukaemia with t(11;19)British Journal of Haematology, 1990
- Kidney Size at Diagnosis of Childhood Acute Lymphocytic LeukemiaJournal of Pediatric Hematology/Oncology, 1988
- Die Corticosteroid-abhängige Dezimierung der Leukämiezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leukämie im Kindesalter (Therapiestudie ALL-BFM 83)Klinische Padiatrie, 1987
- Report and recommendations of the rome workshop concerning poor‐prognosis acute lymphoblastic leukemia in children: Biologic bases for staging, stratification, and treatmentMedical and Pediatric Oncology, 1986